Primary Menu
Skip to content
Lycera
About Us
Corporate Overview
Management Team
Board of Directors
Expanded Access
Programs
LYC-55716
ATPase Modulators
New IO Targets
Pipeline
Investors
Investors
Investor FAQ’s
Contact Us
News & Events
Press Releases
Lycera in the News
Careers
Contact Us
Merck ups autoimmune prize to $600M for small Michigan biotech
Mar 7, 2013
FierceBiotech